Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Shenzhen - Delayed Quote CNY

Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)

Compare
5.82
-0.09
(-1.52%)
As of 12:45:10 PM GMT+8. Market Open.
Loading Chart for 300318.SZ
  • Previous Close 5.91
  • Open 5.92
  • Bid 5.82 x --
  • Ask 5.83 x --
  • Day's Range 5.80 - 5.89
  • 52 Week Range 4.50 - 7.17
  • Volume 3,595,300
  • Avg. Volume 6,864,465
  • Market Cap (intraday) 4.754B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.02
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 12, 2018
  • 1y Target Est --

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.

www.bohui-tech.com

1,961

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300318.SZ

View More

Performance Overview: 300318.SZ

Trailing total returns as of 3/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index .

YTD Return

300318.SZ
1.75%
SSE Composite Index
0.04%

1-Year Return

300318.SZ
27.35%
SSE Composite Index
9.18%

3-Year Return

300318.SZ
29.71%
SSE Composite Index
1.22%

5-Year Return

300318.SZ
19.75%
SSE Composite Index
12.86%

Compare To: 300318.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300318.SZ

View More

Valuation Measures

Annual
As of 3/10/2025
  • Market Cap

    4.83B

  • Enterprise Value

    5.71B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.46

  • Price/Book (mrq)

    3.47

  • Enterprise Value/Revenue

    6.45

  • Enterprise Value/EBITDA

    60.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.73%

  • Return on Assets (ttm)

    1.12%

  • Return on Equity (ttm)

    1.96%

  • Revenue (ttm)

    885.39M

  • Net Income Avi to Common (ttm)

    -15.35M

  • Diluted EPS (ttm)

    -0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    118.36M

  • Total Debt/Equity (mrq)

    42.04%

  • Levered Free Cash Flow (ttm)

    -228.66M

Research Analysis: 300318.SZ

View More

Company Insights: 300318.SZ

Research Reports: 300318.SZ

View More

People Also Watch